F M Lemoine
Overview
Explore the profile of F M Lemoine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Moignic A, Malard V, Benvegnu T, Lemiegre L, Berchel M, Jaffres P, et al.
J Control Release
. 2018 Apr;
278:110-121.
PMID: 29630987
Clinical trials with direct administration of synthetic mRNAs encoding tumor antigens demonstrated safety and induction of tumor-specific immune responses. Their proper delivery to dendritic cells (DCs) requires their protection against...
2.
Petit N, Baillou C, Burlion A, Dorgham K, Levacher B, Amiel C, et al.
Gene Ther
. 2015 Oct;
23(2):144-50.
PMID: 26488891
Targeting viral entry is the most likely gene therapy strategy to succeed in protecting the immune system from pathogenic HIV-1 infection. Here, we evaluated the efficacy of a gene transfer...
3.
Maury S, Rosenzwajg M, Redjoul R, Marcais A, Xhaard A, Cherai M, et al.
Leukemia
. 2014 Aug;
28(12):2406-10.
PMID: 25102947
No abstract available.
4.
Perrot A, Pionneau C, Azar N, Baillou C, Lemoine F, Leblond V, et al.
Blood Cancer J
. 2012 Sep;
2:e88.
PMID: 22961060
Waldenström's macroglobulinemia (WM) is a clonal B-cell lymphoproliferative disorder (LPD) of post-germinal center nature. Despite the fact that the precise molecular pathway(s) leading to WM remain(s) to be elucidated, a...
5.
Yao M, Fouillard L, Lemoine F, Bouchet S, Firat H, Andreu G, et al.
Bone Marrow Transplant
. 2000 Oct;
26(5):497-503.
PMID: 11019838
The aim of the present study was to evaluate the capacity to expand of hematopoietic stem cell (HSC) samples from eight patients with NHL, and to follow in parallel the...
6.
Movassagh M, Boyer O, Burland M, Leclercq V, Klatzmann D, Lemoine F
Hum Gene Ther
. 2000 Jun;
11(8):1189-200.
PMID: 10834620
This study was designed to retrovirally transduce T cells by a protocol that would be simple, short, cost effective, applicable for clinical use, and efficient enough to avoid further selection...
7.
Colombo B, Lacave R, Masurier C, Lemoine F, GUIGON M, Klatzmann D
Immunology
. 2000 Jan;
99(1):8-15.
PMID: 10651935
Dendritic cells (DC) are extremely efficient at generating both prophylactic and therapeutic anti-tumour immunity. We aimed to analyse the respective roles of humoral and cellular immune responses generated in mice...
8.
Schneider E, Lemoine F, BRETON-GORIUS J, Machavoine F, Arnould A, Cramer E, et al.
Exp Hematol
. 1999 Jun;
27(6):1010-8.
PMID: 10378890
Murine low-density bone marrow cells sorted from the blast cell window on the basis of high rhodamine-123 retention (Rh-bright), are highly enriched in histamine-, IL-4-, and IL-6-producing cells. We established...
9.
Masurier C, Colombo B, Lacave R, Lemoine F, Klatzmann D, GUIGON M
Immunology
. 1999 May;
96(4):569-77.
PMID: 10233743
Dendritic cells (DC) are professional antigen-presenting cells that can be used as immune adjuvant for anti-tumoural therapies. This approach requires the generation of large quantities of DC that are fully...
10.
Movassagh M, Baillou C, Cosset F, Klatzmann D, GUIGON M, Lemoine F
Hum Gene Ther
. 1999 Feb;
10(2):175-87.
PMID: 10022543
Dendritic cells (DCs), the most potent antigen-presenting cells, can be generated from CD34+ hematopoietic stem cells and used for generating therapeutic immune responses. To develop immunotherapy protocols based on genetically...